{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:22:43Z","timestamp":1788340963334,"version":"build-2803163510"},"reference-count":9,"publisher":"Centers for Disease Control MMWR Office","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7107e1","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T16:16:16Z","timestamp":1644596176000},"page":"249-254","source":"Crossref","is-referenced-by-count":82,"title":["Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults \u2014 United States, September 22, 2021\u2013February 6, 2022"],"prefix":"10.15585","volume":"71","author":[{"given":"Anne M.","family":"Hause","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Baggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya R.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip G.","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Gwira Baumblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Jane","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Shay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"key-10.15585\/mmwr.mm7107e1-202202171000-R1","unstructured":"Food and Drug Administration. Pfizer-BioNTech COVID-19 vaccine letter of authorization. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https:\/\/www.fda.gov\/media\/150386\/download"},{"key":"key-10.15585\/mmwr.mm7107e1-202202171000-R2","unstructured":"Food and Drug Administration. Moderna COVID-19 vaccine decision memorandum. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https:\/\/www.fda.gov\/media\/154405\/download"},{"key":"key-10.15585\/mmwr.mm7107e1-202202171000-R3","unstructured":"Food and Drug Administration. Janssen COVID-19 vaccine decision memorandum. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https:\/\/www.fda.gov\/media\/154359\/download"},{"key":"key-10.15585\/mmwr.mm7107e1-202202171000-R4","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.mm7107e1-202202171000-R5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination, United States, December 2020\u2013August 2021.","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm7107e1-202202171000-R6","unstructured":"Gruber WC. BNT162b2 [COMIRNATY (COVID-19 vaccine, mRNA)] booster (third) dose. Advisory Committee on Immunization Practices meeting; September 22, 2021; Atlanta, Georgia. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-09-22\/02-COVID-Gruber-508.pdf"},{"key":"key-10.15585\/mmwr.mm7107e1-202202171000-R7","unstructured":"Miller J. Safety and immunogenicity of a 50 \u00b5g booster dose of Moderna COVID-19 vaccine. Advisory Committee on Immunization Practices meeting; October 21, 2021; Atlanta, Georgia. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-10-20-21\/02-COVID-Miller-508.pdf"},{"key":"key-10.15585\/mmwr.mm7107e1-202202171000-R8","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1001\/jama.2021.5374","article-title":"Reactogenicity following receipt of mRNA-based COVID-19 vaccines.","volume":"325","author":"Chapin-Bardales","year":"2021","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm7107e1-202202171000-R9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.15585\/mmwr.mm7044e2","article-title":"The Advisory Committee on Immunization Practices\u2019 Interim recommendations for additional primary and booster doses of COVID-19 vaccines\u2014United States, 2021.","volume":"70","author":"Mbaeyi","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T15:01:00Z","timestamp":1645110060000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7107e1.htm?s_cid=mm7107e1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":9,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,2,18]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7107e1","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,18]]},"published":{"date-parts":[[2022,2,18]]}}}